WuXi AppTec
Business Services · China · 10K+ Employees
View Company Info for Free
Overview
Headquarters
288 Free Trade Zone, Shanghai, Shanghai,...Phone Number
+86 2150461111Website
www.wuxiapptec.comRevenue
$6.4 BillionStock Symbol
WUXAYIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
3
4
1
2
2
About WuXi AppTec
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.Explore more
WuXi AppTec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is WuXi AppTec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if WuXi AppTec has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on WuXi AppTec recently announced quarterly report
Click to see if WuXi AppTec had a recent Job posting/layoffs
Product Launch: Get notified when WuXi AppTec launches new products
Congratulate Masked Content for being promoted to Masked Content at WuXi AppTec
WuXi AppTec, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once WuXi AppTec has new funding data
Check out if WuXi AppTec is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined WuXi AppTec as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
WuXi AppTec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
WuXi AppTec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about WuXi AppTec.
WuXi AppTec financials insights
Gather financial insights about WuXi AppTec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$184.6M
2016
Debt
$1.5B
2024
Other Financing Round
$500M
WuXi AppTec Tech Stack
A closer look at the technologies used by WuXi AppTec
See more technologies
Most Recent Scoops
Person-Based
David Madge commented on the evolving drug R&D landscape driven by advances in small molecule drugs.
Research & Development, Pharmaceuticals
Person-Based
Facilities Relocation/Expansion, Logistics / Supply Chain
Person-Based
Pharmaceuticals
Event
Product Marketing, Events, eCommerce, Sales, Software, Device Management, Field /Outside Sales, Corporate Strategy, Field Marketing, Healthcare Operations, Healthcare Technology, Operations, Radiology
WuXi AppTec News & Media
Smart Compound Stewardship for DMPK: WuXi AppTec DMPK’s Automated Compound Management with Full-Process Traceability
SAN DIEGO , CA, UNITED STATES, July 7, 2026 /EINPresswire.com/ -- Leveraging over 15 years of laboratory operational expertise, WuXi AppTec DMPK has provided compound management services to thousands of pharmaceutical and biotechnology companies …Integrated Development Helps Targeted Protein Degraders Reach the Clinic
WuXi AppTec shows how integrated CRDMO platforms help protein degrader programs reach the clinic by connecting chemistry, biology, and CMC early.Complex Small Molecules Are Changing Drug R&D
WuXi AppTec details how structural complexity in protein degraders, covalent agents, and kinase programs is reshaping what integrated CRDMOs must deliver.WuXi AppTec Builds a Flexible Global Manufacturing Network Around Customer Choice
SHANGHAI, SHANGHAI, CHINA, June 12, 2026 /EINPresswire.com/ -- As pharmaceutical companies increasingly seek resilient and flexible supply chains, WuXi AppTec is expanding manufacturing capabilities across the United States, Europe, and Asia with a focus …
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding WuXi AppTec
Sign Up For FreeTo access detailed company insights
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi... Read More
